Click on headlines below to download research
Royalty investing is a profitable and significant form of alternative finance in North America. However, it is still a nascent industry in Europe and Duke…
Following the end of Q3, we have revised our earnings forecasts for Endeavour to reflect a higher gold price (a likely quarterly average of US$1,474/oz…
Newron Pharmaceuticals’ interim results highlight that despite additional worldwide launches of Xadago, sales growth in the US and Europe remain…
The acquisition of Harry Peers & Co brings additional expertise to the Severfield portfolio, with particular strengths in relatively robust infrastructure…
At the 2019 European Society for Medical Oncology (ESMO) conference, Transgene presented the first efficacy data for TG4001 in combination with avelumab…